HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yung-Jue Bang Selected Research

PF-03732010 monoclonal antibody

8/2012Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yung-Jue Bang Research Topics

Disease

194Neoplasms (Cancer)
03/2024 - 04/2002
120Stomach Neoplasms (Stomach Cancer)
05/2024 - 04/2002
43Adenocarcinoma
12/2023 - 07/2002
40Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 06/2002
39Breast Neoplasms (Breast Cancer)
01/2020 - 03/2004
25Neoplasm Metastasis (Metastasis)
01/2023 - 10/2003
18Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2023 - 12/2008
18Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 11/2005
17Carcinoma (Carcinomatosis)
01/2024 - 07/2003
16Disease Progression
01/2023 - 10/2012
12Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 07/2004
10Diarrhea
07/2022 - 02/2011
10Hepatocellular Carcinoma (Hepatoma)
01/2020 - 03/2002
10Lung Neoplasms (Lung Cancer)
01/2015 - 01/2003
8Nausea
12/2023 - 02/2009
8Carcinogenesis
01/2013 - 10/2003
7Neutropenia
12/2021 - 08/2010
7Ataxia Telangiectasia (Louis Bar Syndrome)
07/2020 - 01/2013
6Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2023 - 01/2009
6Microsatellite Instability
12/2021 - 05/2013
6Vomiting
07/2017 - 12/2004
5Fatigue
01/2021 - 02/2011
5Triple Negative Breast Neoplasms
07/2017 - 11/2007
4Pneumonia (Pneumonitis)
12/2023 - 12/2013
4Thrombocytopenia (Thrombopenia)
12/2021 - 10/2015
4Colonic Neoplasms (Colon Cancer)
06/2017 - 10/2011
4Cholangiocarcinoma
04/2017 - 10/2015

Drug/Important Bio-Agent (IBA)

34Fluorouracil (Carac)FDA LinkGeneric
12/2023 - 01/2003
31Cisplatin (Platino)FDA LinkGeneric
12/2023 - 11/2002
26Trastuzumab (Herceptin)FDA Link
12/2021 - 01/2008
26Proteins (Proteins, Gene)FDA Link
01/2020 - 03/2002
23ErbB Receptors (EGF Receptor)IBA
05/2024 - 01/2005
22Paclitaxel (Taxol)FDA LinkGeneric
03/2024 - 01/2003
22pembrolizumabIBA
12/2023 - 06/2016
19Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2023 - 05/2008
18human ERBB2 proteinIBA
01/2023 - 10/2008
17Capecitabine (Xeloda)FDA Link
01/2023 - 07/2004
16Biomarkers (Surrogate Marker)IBA
05/2024 - 04/2004
16PlatinumIBA
03/2024 - 01/2005
15Monoclonal AntibodiesIBA
10/2023 - 08/2010
14GemcitabineFDA Link
10/2021 - 06/2006
14Lapatinib (GW572016)FDA Link
01/2020 - 03/2008
14Tyrosine Kinase InhibitorsIBA
07/2018 - 11/2007
13Leucovorin (Folinic Acid)FDA Link
12/2023 - 07/2004
11Histone Deacetylase InhibitorsIBA
03/2015 - 03/2004
10CrizotinibIBA
11/2014 - 10/2010
10Doxorubicin (Adriamycin)FDA LinkGeneric
04/2013 - 12/2003
8Anaplastic Lymphoma KinaseIBA
10/2012 - 10/2010
8DNA (Deoxyribonucleic Acid)IBA
08/2012 - 04/2004
8Gefitinib (Iressa)FDA Link
02/2012 - 01/2005
7B7-H1 AntigenIBA
01/2021 - 11/2016
7Phosphotransferases (Kinase)IBA
01/2021 - 05/2009
7olaparibIBA
02/2020 - 01/2013
7Sunitinib (Sutent)FDA Link
12/2016 - 01/2011
7Docetaxel (Taxotere)FDA Link
04/2013 - 07/2002
6Immune Checkpoint InhibitorsIBA
02/2024 - 01/2019
6Irinotecan (Camptosar)FDA LinkGeneric
12/2023 - 09/2008
6LigandsIBA
08/2021 - 08/2017
6Messenger RNA (mRNA)IBA
05/2019 - 06/2003
6Cetuximab (Erbitux)FDA Link
01/2019 - 03/2008
6AntigensIBA
12/2017 - 04/2002
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2016 - 09/2011
6Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2016 - 12/2008
6Histones (Histone)IBA
07/2012 - 08/2005
6Histone Deacetylases (Histone Deacetylase)IBA
08/2010 - 12/2003
6Transforming Growth Factor beta1 (TGF beta 1)IBA
08/2005 - 03/2002
5trastuzumab deruxtecanIBA
05/2024 - 01/2020
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023 - 09/2009
5Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2023 - 01/2013
5Transforming Growth Factor beta (TGF-beta)IBA
01/2020 - 03/2002
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2017 - 05/2011
5Imatinib Mesylate (Gleevec)FDA Link
11/2012 - 01/2009
5Pemetrexed (MTA)FDA Link
09/2011 - 06/2005
5Thymidylate SynthaseIBA
07/2011 - 12/2006
4GC1118IBA
12/2023 - 01/2019
4Immunoglobulin G (IgG)IBA
10/2023 - 08/2012
4Protein Isoforms (Isoforms)IBA
01/2023 - 09/2004
4ceralasertibIBA
07/2020 - 01/2017
4HM781-36BIBA
11/2019 - 03/2011
4Hormones (Hormone)IBA
01/2018 - 02/2010
4EverolimusFDA Link
11/2014 - 12/2010
4Complementary DNA (cDNA)IBA
03/2012 - 04/2002
4belotecanIBA
02/2012 - 01/2006
4MethyltransferasesIBA
06/2010 - 04/2004
4NF-kappa B (NF-kB)IBA
05/2009 - 09/2004
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2009 - 10/2003
4hydrogen sulfite (bisulfite)IBA
09/2004 - 07/2003
3zolbetuximabIBA
10/2023 - 01/2023
3Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 01/2003

Therapy/Procedure

119Drug Therapy (Chemotherapy)
12/2023 - 11/2002
78Therapeutics
02/2024 - 12/2003
21Radiotherapy
09/2017 - 06/2002
17Adjuvant Chemotherapy
12/2023 - 12/2004
17Adjuvant Chemoradiotherapy
09/2017 - 11/2005
15Combination Drug Therapy (Combination Chemotherapy)
09/2014 - 01/2003
13Chemoradiotherapy
10/2021 - 06/2002
11Neoadjuvant Therapy
12/2016 - 05/2004
9Gastrectomy
01/2023 - 07/2008
5Induction Chemotherapy
01/2021 - 06/2002
4Adjuvant Radiotherapy
01/2016 - 07/2010